Detalles de la búsqueda
1.
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 25(11)2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38892246
2.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696892
3.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 267-276, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539744
4.
DPD status and fluoropyrimidines-based treatment: high activity matters too.
BMC Cancer
; 20(1): 436, 2020 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423482
5.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Cancer
; 122(20): 3119-3126, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412268
6.
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
Oncologist
; 20(8): 873-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26112003
7.
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
Support Care Cancer
; 21(7): 1947-54, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23420555
8.
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Breast Cancer
; 30(2): 315-328, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36602669
9.
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
J Clin Oncol
; 41(30): 4768-4778, 2023 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37643382
10.
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
Breast Cancer Res Treat
; 131(1): 127-35, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947680
11.
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.
Front Pharmacol
; 12: 711813, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616296
12.
Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view.
Psychooncology
; 19(5): 472-9, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19507263
13.
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Clin Cancer Res
; 15(10): 3633-9, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19401344
14.
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy.
Eur J Cancer
; 117: 99-106, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279306
15.
[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]. / Attentes des patientes suivies pour un cancer de l'ovaire concernant les traitements d'entretien : résultats de la cohorte française GINECO de l'enquête européenne NOGGO/ENGOT-ov22 (Expression IV).
Bull Cancer
; 105(5): 465-474, 2018 May.
Artículo
en Francés
| MEDLINE | ID: mdl-29544693
16.
Predicting early death in older adults with cancer.
Eur J Cancer
; 100: 65-74, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014882
17.
Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.
Radiother Oncol
; 85(3): 355-61, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18023492
18.
Decision-making and breast cancer clinical trials: how experience challenges attitudes.
Contemp Clin Trials
; 28(6): 684-94, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17434812
19.
Pharmacogenetics of capecitabine in advanced breast cancer patients.
Clin Cancer Res
; 12(18): 5496-502, 2006 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17000685
20.
Self-management strategies adopted by breast cancer survivors to improve their adherence to tamoxifen.
Breast J
; 18(4): 389-91, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22640035